Profound Medical Corp. (PRN.TO)
9.83
-0.01
(-0.10%)
CAD |
TSX |
Oct 09, 16:00
Profound Medical Gross Profit Margin (Quarterly) : 78.41% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.41% |
| March 31, 2026 | 71.80% |
| December 31, 2025 | 66.77% |
| September 30, 2025 | 74.32% |
| June 30, 2025 | 73.18% |
| March 31, 2025 | 70.70% |
| December 31, 2024 | 70.94% |
| September 30, 2024 | 63.77% |
| June 30, 2024 | 64.40% |
| March 31, 2024 | 66.44% |
| December 31, 2023 | 51.82% |
| September 30, 2023 | 60.30% |
| June 30, 2023 | 64.54% |
| March 31, 2023 | 64.25% |
| December 31, 2022 | 44.47% |
| September 30, 2022 | 53.56% |
| June 30, 2022 | 46.22% |
| March 31, 2022 | 31.96% |
| December 31, 2021 | 49.80% |
| Date | Value |
|---|---|
| September 30, 2021 | 38.90% |
| June 30, 2021 | 46.29% |
| March 31, 2021 | 35.44% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 65.83% |
| June 30, 2020 | 40.52% |
| March 31, 2020 | 38.11% |
| December 31, 2019 | 57.45% |
| September 30, 2019 | 6.07% |
| June 30, 2019 | -32.45% |
| March 31, 2019 | 63.86% |
| December 31, 2018 | 30.84% |
| September 30, 2018 | -116.0% |
| June 30, 2018 | -158.8% |
| March 31, 2018 | -73.37% |
| December 31, 2017 | 23.57% |
| September 30, 2017 | -4.60% |
| June 30, 2017 | 43.27% |
| March 31, 2017 | 36.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| MedMira, Inc. | -26.66% |
| MedX Health Corp. | 27.96% |
| VentriPoint Diagnostics Ltd. | -258.1% |
| Theralase Technologies, Inc. | 21.12% |
| VVT Med, Inc. | 45.51% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -65.99% |
| Return on Assets | -44.31% |
| Return on Invested Capital | -59.02% |
| Profit Margin (Quarterly) | -384.2% |
| Operating Margin (Quarterly) | -445.7% |
| Return on Net Operating Assets | -188.6% |